Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial Paper
QFRD304385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
27,477.00
Year-over-Year Change
11.44%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks short-term debt for U.S. pharmaceutical and medicine corporations with original maturities of one year or less. The metric provides critical insights into corporate financial liquidity and short-term borrowing strategies in a key healthcare sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The data represents other short-term loans, including commercial paper, which indicates how pharmaceutical companies manage their immediate financial obligations and working capital needs. Economists use this metric to assess corporate financial health, credit market conditions, and potential investment risks.
Methodology
Data is collected through quarterly financial reports submitted by corporations to regulatory agencies, then compiled and standardized by the Federal Reserve.
Historical Context
This trend is used in macroeconomic analysis to understand corporate financing patterns, credit market dynamics, and sector-specific financial strategies.
Key Facts
- Measures short-term debt for U.S. pharmaceutical corporations
- Includes commercial paper and loans with less than one-year maturity
- Provides insights into corporate financial liquidity and borrowing strategies
FAQs
Q: What does this economic trend measure?
A: It tracks short-term debt for U.S. pharmaceutical and medicine corporations, including commercial paper and loans with original maturities of one year or less.
Q: Why is this trend important for investors?
A: It offers insights into corporate financial health, liquidity, and potential investment risks in the pharmaceutical sector.
Q: How often is this data updated?
A: The data is typically updated quarterly through financial reports submitted by corporations.
Q: What can this trend reveal about the healthcare sector?
A: It provides information about corporate financing strategies, credit market conditions, and short-term financial management in the pharmaceutical industry.
Q: Are there limitations to this economic indicator?
A: The data represents a snapshot of short-term debt and may not capture long-term financial strategies or overall corporate performance.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Capital Stock and Other Capital (Less Treasury Stock)
QFRD326545USNO
Quarterly Financial Report: U.S. Corporations: Wood Products: All Other Operating Costs and Expenses
QFR103321USNO
Quarterly Financial Report: U.S. Corporations: Food: Long-Term Debt, Due in More Than 1 Year: Loans from Banks
QFR316311USNO
Quarterly Financial Report: U.S. Corporations: Primary Metals: All Other Operating Costs and Expenses
QFR103PRIUSNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Net Sales, Receipts, and Operating Revenues
QFR101326USNO
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Net Property, Plant, and Equipment
QFR219546USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial Paper [QFRD304385USNO], retrieved from FRED.
Last Checked: 8/1/2025